Abstract
Ataxia-telangiectasia (A-T) is a rare hereditary disorder characterized by progressive cerebellar ataxia, conjunctival telangiectasias, recurrent sinopulmonary infections, radiosensitivity, and a predisposition to malignancy. It is the most common cause of progressive cerebellar ataxia in childhood. The prevalence is estimated to be 1 in 40,000–1 in 100,000 live births.
References
Ammann, A. J., Cain, W. A., Ishizaka, K., et al. (1969). Immunoglobulin E deficiency in ataxia-telangiectasia. The New England Journal of Medicine, 281, 469–472.
Bhatt, J. M., Bush, A., van Gerven, M., et al. (2015). ERS statement on the multidisciplinary respiratory management of ataxia telangiectasia. European Respiratory Review, 24, 565–581.
Chen, Z., Ye, W., Long, Z., et al. (2015). Targeted next-generation sequencing revealed novel mutations in Chinese ataxia telangiectasia patients: aa precision medicine perspective. PLoS ONE, 10, e0139738.
Chessa, L., Piane, M., Prudente, S., et al. (1999). Molecular prenatal diagnosis of ataxia telangiectasia heterozygosity by direct mutational assays. Prenatal Diagnosis, 19, 542–545.
Chun, H. H., & Gatti, R. A. (2004). Ataxia-telangiectasia, an evolving phenotype (Review). DNA Repair, 3, 1187–1196.
Concannon, P., & Gatti, R. A. (1997). Diversity of ATM gene mutations detected in patients with ataxia-telangiectasia. Human Mutation, 10, 100–107.
Dawson, A. J., Markles, S., Tomiuk, M., et al. (2015). Ataxia-telangiectasia with female fertility. American Journal of Medical Genetics Part A, 167A, 1937–1939.
Frappart, P.-O., & McKinnon, P. J. (2006). Ataxia-telangiectasia and related diseases. Neuromolecular Medicine, 8, 495–511.
Gatti, R. A. (1997). Diversity of ATM gene mutations detected in patients with ataxia-telangiectasia. Human Mutation, 10, 100–107.
Gatti, R. A. (2010). Ataxia-telangiectasia. GeneReviews. Updated 11 Mar 2010. Available at: http://www.ncbi.nlm.nih.gov/books/NBK26468/
Gatti, R. A., & Perlman, S. (2009). A proposed bailout for A-T patients? European Journal of Neurology, 16, 653–655.
Gatti, R. A., Boder, E., Vinters, H., et al. (1991). Ataxia-telangiectasia: An interdisciplinary approach to pathogenesis. Medicine, 70, 99–117.
Greenberger, S., Berkun, Y., Ben-Zeev, B., et al. (2013). Dermatologic manifestations of ataxia-telangiectasia syndrome. Journal of American Academy of Dermatology, 68, 932–936.
Janniger, C. K. (2015). Ataxia-telangiectasia. eMedicine from WebMD. Updated 22 Oct 2015. Available at: http://emedicine.medscape.com/article/1113394-overview
Lavin, M. R. (2008). Ataxia-telangiectasia: From a rare disorder to a paradigm for cell signalling and cancer. Nature Reviews Molecular Cell Biology, 9, 759–769.
Lin, D. D., Barker, P. B., Lederman, H. M., et al. (2014). Cerebral abnormalities in adults with ataxia-telangiectasia. AJNR American Journal of Neurodadiology, 35, 119–123.
Mancebo, E., Bernardo, I., Castro, M. J., et al. (2007). Rapid molecular prenatal diagnosis of ataxia-telangiectasia by direct mutational analysis. Prenatal Diagnosis, 27, 861–864.
Mavrou, A., Tsangaris, G. H., Roma, E., et al. (2008). The ATM gene and ataxia telangiectasia. Anticancer Research, 28, 401–406.
Metcalfe, J. A., Parkhill, J., Campbell, L., et al. (1996). Accelerated telomere shortening in ataxia telangiectasia. Nature Genetics, 13, 350–353.
Meyn, M. S. (1999). Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene. Clinical Genetics, 55, 289–304.
Nowak-Wegrzyn, A., Crawford, T. O., Winkelstein, J. A., et al. (2004). Immunodeficiency and infections in ataxia-telangiectasia. Journal of Pediatrics, 144, 505–511.
Perlman, S., Becker-Catania, S., & Gatti, R. A. (2003). Ataxia-telangiectasia: Diagnosis and treatment. Seminars in Pediatric Neurology, 10, 173–182.
Regueiro, J. R., Porras, O., Lavin, M., et al. (2000). Ataxia-telangiectasia. A primary immunodeficiency revisited. Immunology and Allergy Clinics of North America, 20(1), 177–206.
Sahama, I., Sinclair, K., Pannek, K., et al. (2014). Radiological imaging in ataxia telangiectasia: A review. Cerebellum, 13, 521–530.
Sanal, O., Ersoy, F., Yel, L., et al. (1999). Impaired IgG antibody production to pneumococcal polysaccharides in patients with ataxia-telangiectasia. Journal of Clinical Immunology, 19, 326–334.
Sauma, L. S., Teixeira, K. C. S., & Montenegro, M. A. (2015). Ataxia telangiectasia. Rua Tessália Vieira de Camargo, 126, 13083–13887.
Stankovic, T., Kidd, A. M. J., Sutcliffe, A., et al. (1998). ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: Expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. American Journal of Human Genetics, 62, 334–345.
Sun, X., Becker-Catania, S. G., Chun, H. H., et al. (2002). Early diagnosis of ataxia-telangiectasia using radiosensitivity testing. Journal of Pediatrics, 140, 724–731.
Swift, M., Reitnauer, P. J., Morrell, D., et al. (1987). Breast and other cancers in families with ataxia-telangiectasia. The New England Journal of Medicine, 316, 1289–1294.
Swift, M., Morrell, D., Massey, R. B., et al. (1991). Incidence of cancer in 161 families affected by ataxia-telangiectasia. The New England Journal of Medicine, 325, 1831–1836.
Tangsinmankong, N., Wayne, A. S., Howenstine, M. S., et al. (2001). Lymphocytic interstitial pneumonitis, elevated IgM concentration, and hepatosplenomegaly in ataxia-telangiectasia. Journal of Pediatrics, 138, 939–941.
Taylor, A. M. R., & Byrd, P. J. (2005). Molecular pathology of ataxia telangiectasia. Journal of Clinical Pathology, 58, 1009–1015.
Taylor, A. M., Metcalfe, A. J. A., Thick, J., et al. (1996). Leukemia and lymphoma in ataxia telangiectasia. Blood, 87, 423–438.
Taylor, A. M. R., Lam, Z., Last, J. I., et al. (2015). Ataxia telangiectasia: More variation at clinical and cellular levels. Clinical Genetics, 87, 199–208.
Telatar, M., Teraoka, S., Wang, Z., et al. (1998). Ataxia-telangiectasia: Identification and detection of founder-effect mutations in the ATM gene in ethnic populations. American Journal of Human Genetics, 62, 86–97.
Weiss, B., Krauthammer, A., Soudack, M., et al. (2015). Liver disease in pediatric patients with ataxia telangiectasia: A novel report. JPGN Journal of Pediatric Gastroenterology and Nutrition, 19 Nov. [Epublish ahead of print].
Weyemi, U., Redon, C. E., Aziz, T., et al. (2015). NADPH oxidase 4 is a critical mediator in ataxia telangiectasia disease. Proceedings of the National Academy of Sciences of the United States of America, 112, 2121–2126.
Woods, C. G., & Taylor, A. M. R. (1992). Ataxia-telangiectasia in the British Isles: The clinical and laboratory features of 70 affected individuals. Quarterly Journal of Medicine, 82, 169–179.
Worth, P. F., Srinivasan, V., Smith, A., et al. (2013). Very mild presentation in adult with classical cellular phenotype of ataxia telangiectasia. Movement Disorders, 28, 524–528.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this entry
Cite this entry
Chen, H. (2017). Ataxia-Telangiectasia. In: Atlas of Genetic Diagnosis and Counseling. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2401-1_18
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2401-1_18
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2400-4
Online ISBN: 978-1-4939-2401-1
eBook Packages: MedicineReference Module Medicine